Our partnership with
Parent Project Muscular Dystrophy
Affecting one in 5,000 male births in the U.S., Duchenne is the most common form of muscular dystrophy diagnosed in childhood. Parent Project Muscular Dystrophy (PPMD) leads the way in advancing care, accelerating research, advocating for policy change and ensuring the best possible care for every family.
Support PPMD
Our partnership with
Parent Project Muscular Dystrophy
Affecting one in 5,000 male births in the U.S., Duchenne is the most common form of muscular dystrophy diagnosed in childhood. Parent Project Muscular Dystrophy (PPMD) leads the way in advancing care, accelerating research, advocating for policy change and ensuring the best possible care for every family.
Support PPMD
Make an impact
When you shop with Olivela, 20% of net proceeds from every purchase helps support PPMD's comprehensive efforts to accelerate progress in the fight to end Duchenne. While there is no cure (yet), PPMD’s innovative approach brings more hope than ever before.
Fighting for their futures
PPMD has invested $55 million into Duchenne research and therapy development to date.
Explore our cause partners
View all cause partners
